» Articles » PMID: 14659807

Inhibiting Mitochondrial Permeability Transition Pore Opening at Reperfusion Protects Against Ischaemia-reperfusion Injury

Overview
Journal Cardiovasc Res
Date 2003 Dec 9
PMID 14659807
Citations 139
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The opening of the mitochondrial permeability transition pore (mPTP) in the first few minutes of post-ischaemic reperfusion is a critical determinant of reperfusion-induced cell death. We hypothesised that the novel immunosuppressant, sanglifehrin-A (SFA), given at the time of reperfusion, protects the myocardium from ischaemia-reperfusion injury, by suppressing mPTP opening.

Methods: Isolated perfused rat hearts were subjected to 35 min ischaemia/120 min reperfusion, and were treated with (1) SFA (1.0 microM) or (2) DMSO vehicle for the first 15 min of reperfusion or (3) SFA (1.0 microM) after the first 15 min of reperfusion. We examined the effect of SFA on mPTP opening directly, using a myocyte model of oxidative stress. Laser illumination of adult rat myocytes loaded with the fluorophore, TMRM, generates oxidative stress, which induces mPTP opening (represented by mitochondrial membrane depolarisation) followed by rigour contracture.

Results: In the isolated perfused heart model, SFA, given during the first 15 min of post-ischaemic reperfusion, reduced the infarct-risk volume ratio from 43.9+/-2.5% in the control group to 23.8+/-4.2% with SFA (p=0.001). However, when SFA was given after the first 15 min of reperfusion, there was no change in infarct size (43.8+/-5.7% with SFA vs. 43.9+/-2.5% in control; p=NS), suggesting that SFA has to be present during the first 15 min of reperfusion to induce protection. In the isolated adult myocyte model, SFA was shown to inhibit mPTP opening in the setting of oxidative stress, represented by an increase in the ROS threshold required to induce: mitochondrial membrane depolarisation (from 269+/-21 to 777+/-100 s; p<0.001) and rigour contracture (from 613+/-14 to 1329+/-129 s; p<0.001).

Conclusions: Inhibiting mPTP opening during the first few minutes of reperfusion, using sanglifehrin-A, limits infarct size and protects myocytes from oxidative stress.

Citing Articles

Mechanisms of postischemic cardiac death and protection following myocardial injury.

Mastoor Y, Murphy E, Roman B J Clin Invest. 2025; 135(1).

PMID: 39744953 PMC: 11684816. DOI: 10.1172/JCI184134.


Levosimendan, a Promising Pharmacotherapy in Cardiogenic Shock: A Comprehensive Review.

Susilo H, Aldian F, Kencono Wungu C, Alsagaff M, Sutanto H, Multazam C Eur Cardiol. 2024; 19:e21.

PMID: 39588250 PMC: 11588109. DOI: 10.15420/ecr.2024.16.


Cardioprotective Effect of Chronic Hypoxia Involves Inhibition of Mitochondrial Permeability Transition Pore Opening.

Alanova P, Alan L, Neckar J, Ostadal B, Kolar F Physiol Res. 2024; 73(5):881-884.

PMID: 39560196 PMC: 11629960. DOI: 10.33549/physiolres.935427.


Beneficial effects of resveratrol on diabetes mellitus and its complications: focus on mechanisms of action.

Ahmadzadeh A, Aliabadi M, Mirheidari S, Hamedi-Asil M, Garousi S, Mottahedi M Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39446148 DOI: 10.1007/s00210-024-03527-4.


Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delayed graft function study: study protocol of the CINERGY Pilot randomised controlled trial.

DAragon F, Selzner M, Breau R, Masse M, Lamontagne F, Masse M BMJ Open. 2024; 14(6):e086777.

PMID: 38871657 PMC: 11177676. DOI: 10.1136/bmjopen-2024-086777.